Related references
Note: Only part of the references are listed.Safety and Efficacy of Long-Term Maintenance Therapy with Oral Dose of Rabeprazole 10 mg Once Daily in Japanese Patients with Reflux Esophagitis
Kazuma Fujimoto et al.
INTERNAL MEDICINE (2011)
Changes of gastric histology in patients with erosive oesophagitis receiving long-term lansoprazole maintenance therapy
M. M. Haber et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Current concepts in the management of Helicobacter pylori infection:: the maastricht III consensus report
P. Malfertheiner et al.
GUT (2007)
Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment
KD Bardhan et al.
DIGESTIVE AND LIVER DISEASE (2005)
Pantoprazole - An update of its pharmacological properties and therapeutic use in the management of acid-related disorders
SM Cheer et al.
DRUGS (2003)
Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study
BI Hirschowitz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa
R Lamberts et al.
DIGESTION (2001)
Long-term omeprazole treatment in resistant gastroesophageal reflux disease:: Efficacy, safety, and influence on gastric mucosa
EC Klinkenberg-Knol et al.
GASTROENTEROLOGY (2000)
Share Paper
